RxDoctor Payments DataLook up a doctor →

Justin Cole, NP

Gerontology · Laurel, MSNPI 1588053052

Payments from drug & device makers

$14,392in general payments, 2019–2025

Across 793 payments — averaging $18.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Teva Pharmaceuticals USA, Inc.$867
  • Acadia Pharmaceuticals Inc$780
  • SK Life Science, Inc.$776
  • UCB, Inc.$752
  • Novartis$719
  • plus $9K from 54 others

What the payments were for

  • Food & beverage$14,21099%
  • Education$1831%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)81$1,075
Teva Pharmaceuticals USA, Inc.39$867
Acadia Pharmaceuticals Inc50$780
SK Life Science, Inc.43$776
UCB, Inc.34$752
Novartis51$719
Pfizer40$719
Biogen37$639
Argenx US, Inc.24$507
Amgen(2 entities)31$482
Lilly USA, LLC26$480
AstraZeneca(2 entities)25$475
Jazz Pharmaceuticals Inc.20$464
Otsuka America Pharmaceutical, Inc.17$425
Lundbeck LLC18$343
ANI Pharmaceuticals, Inc.16$343
Avanir Pharmaceuticals, Inc.14$339
Sanofi17$330
Genentech USA, Inc.18$327
Neurocrine Biosciences, Inc.16$288
Catalyst Pharmaceuticals, Inc.10$249
Bristol Myers Squibb15$222
Medtronic15$215
Axsome Therapeutics, Inc.5$197
Biohaven Pharmaceutical Holding Company Ltd.12$192
Neurelis, Inc.3$153
Sunovion Pharmaceuticals Inc.11$152
Eisai Inc.8$142
E.r. Squibb & Sons, L.L.C.9$126
Impel Pharmaceuticals Inc.6$126
MDD US Operations, LLC6$118
Biohaven Pharmaceuticals, Inc.7$99
Kyowa Kirin, Inc.5$96
Takeda Pharmaceuticals U.S.A., Inc.5$91
EMD Serono, Inc.6$91
Alnylam Pharmaceuticals Inc.5$87
Amylyx Pharmaceuticals, Inc.4$83
Corium, LLC4$70
Sumitomo Pharma America, Inc.5$68
Mallinckrodt Hospital Products Inc.3$65
Tanabe Pharma America, Inc.4$63
Acorda Therapeutics, Inc3$63
Livanova USA, Inc.2$55
Merz Pharmaceuticals, LLC2$54
Supernus Pharmaceuticals, Inc.3$49
Johnson & Johnson2$36
CSL Behring1$31
Novocure Inc.1$25
C2n Diagnostics, LLC1$23
Grifols USA, LLC1$22
Xeris Pharmaceuticals, Inc.1$20
ADC Therapeutics America, Inc.1$19
Sanofi-aventis U.S. LLC1$19
Vanda Pharmaceuticals Inc.1$18
Phathom Pharmaceuticals, Inc.1$18
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$16
Mylan Specialty L.p.1$16
Cala Health, Inc.1$16
Amneal Pharmaceuticals LLC1$15
Boston Scientific1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,392 in reported general payments places this provider in the 95th percentile of 66 gerontology providers in Mississippi.

See all gerontology providers in Mississippi

Medicare billing

Part B allowed, 2024
$95,502
Medicare patients
543
Services billed
1,655

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine23$296,518
Rebif RebidoseInterferon Beta-1a/Albumin11$115,578
NuplazidPimavanserin Tartrate23$113,174
VumerityDiroximel Fumarate11$93,067
EliquisApixaban77$59,328
Nurtec OdtRimegepant Sulfate27$49,416
Aimovig AutoinjectorErenumab-Aooe26$31,430
Emgality PenGalcanezumab-Gnlm20$20,490
AptiomEslicarbazepine Acetate11$18,838
Carbidopa-Levodopa ErCarbidopa/Levodopa125$9,445
Levetiracetam262$8,204
Carbamazepine ErCarbamazepine84$7,257
Primidone188$6,585
XareltoRivaroxaban12$6,499
Acetazolamide ErAcetazolamide18$6,424

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$867$296,51823 claims
Acadia Pharmaceuticals IncNuplazid$780$113,17423 claims
PfizerEliquis, Nurtec Odt$719$108,743104 claims
BiogenVumerity$639$93,06711 claims
Sunovion Pharmaceuticals Inc.Aptiom$152$18,83811 claims
Johnson & JohnsonXarelto$36$6,49912 claims
Amneal Pharmaceuticals LLCPyridostigmine Bromide$15$2,07129 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 66 gerontology providers in Mississippi.

Other gerontology in Laurel

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →